|
The state-of-the-art downstream processing areas and technologies
have also been designed to complement the flexibility, capacity
and process flow through the upstream phases, ensuring we
are able to meet the needs of clients requiring process development
from early development stages through to the delivery of purified
product for use in all phases of clinical trials.
The integration
of the upstream and downstream process and facility design
enable Alpha to reduce the normal timelines for process development
and cGMP manufacture of our clients' products resulting in
significant cost savings.
|
